WallStreetZenWallStreetZen

NASDAQ: AVDL
Avadel Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Avadel Pharmaceuticals revenue was $169.12M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $50.4M, up 0.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVDL annual revenue was $169.1M, with 504.8% growth year-over-year.

AVDL past revenue growth

How has AVDL's revenue growth performed historically?

Company
504.79%
Industry
13.95%
Market
14.46%
AVDL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AVDL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AVDL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AVDL revenue history

Current Revenue
$169.1M
Current Earnings
-$48.8M
Current Profit Margin
-28.9%

Be the first to know when AVDL announces revenue.

AVDL Revenue History By Year

AVDL Yearly RevenueAVDL RevenueAVDL ChangeAVDL Revenue Growth
2024-12-31$169.12M$141.15M+504.79%
2023-12-31$27.96MN/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00-$22.33M-100.00%
2020-12-31$22.33M-$36.88M-62.28%
2019-12-31$59.22M-$44.05M-42.66%
2018-12-31$103.27M-$69.98M-40.39%
2017-12-31$173.25M$23.00M+15.31%
2016-12-31$150.25M-$22.76M-13.16%
2015-12-31$173.01M$158.03M+1,055.32%
2014-12-31$14.98M$10.80M+258.34%
2013-12-31$4.18M-$3.36M-44.53%
2012-12-31$7.53M-$25.07M-76.89%
2011-12-31$32.60M-$4.49M-12.12%
2010-12-31$37.09M-$5.02M-11.93%
2009-12-31$42.12M$3.50M+9.06%
2008-12-31$38.62M$1.97M+5.36%
2007-12-31$36.65M$13.63M+59.23%
2006-12-31$23.02M-$578.00k-2.45%
2005-12-31$23.60M-$31.81M-57.41%
2004-12-31$55.41M$30.24M+120.17%
2003-12-31$25.17M$6.76M+36.73%
2002-12-31$18.41M$5.32M+40.64%
2001-12-31$13.09M$2.19M+20.04%
2000-12-31$10.90MN/AN/A

1 of 2

Avadel Pharmaceuticals Revenue FAQ

What was AVDL's revenue last quarter?

Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q4 2024 revenue of $50.41 million up 159.14% year over year. In the same quarter last year, Avadel Pharmaceuticals's revenue was $19.45 million.

What was Avadel Pharmaceuticals's revenue in 2024?

Avadel Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $169.12 million, a 504.79% increase year over year.

How much does Avadel Pharmaceuticals make in a day?

Based on Avadel Pharmaceuticals annual revenue for the past five years, AVDL makes an average of $120,226.85 per day.

What was Avadel Pharmaceuticals's annual revenue growth in the past year?

As of Q1 2025, Avadel Pharmaceuticals's revenue has grown 504.79% year over year. This is 490.83 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 13.95%. Avadel Pharmaceuticals's revenue in the past year totaled $169.12 million.

How much does Avadel Pharmaceuticals make in a year?

Avadel Pharmaceuticals's revenue by year for the past five years is:
  • Avadel Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $169.12 million, a 504.79% increase year over year.
  • Avadel Pharmaceuticals's annual revenue for Dec 31, 2023 was $27.96 million, a Infinity% increase from 2022.
  • Avadel Pharmaceuticals's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Avadel Pharmaceuticals's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
  • Avadel Pharmaceuticals's annual revenue for 2020 was $22.33 million, a 62.28% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.